NCT00000711View on ClinicalTrials.gov

Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC

PHASE1CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

Not specified

Study Completion Date

May 31, 1990

Conditions

HIV InfectionsCytopenias

Interventions

DRUG

Zidovudine

DRUG

Sargramostim

Trial Locations (1)

14215

SUNY / Erie County Med Ctr at Buffalo, Buffalo

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH